Q5105 is a HCPCS code for the injection of epoetin alfa-epbx (Retacrit) in 100-unit increments, used to treat symptomatic anemia in patients with end stage renal disease on dialysis.
HCPCS Code Q5105: Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for ESRD on dialysis), 100 units
Learn about HCPCS Code Q5105 for epoetin alfa-epbx (Retacrit) in ESRD dialysis patients, treating anemia and reducing blood transfusion needs.
Use Code
Frequently asked questions
Yes. Under the ESRD PPS bundle, Q5105 is covered for ESRD patients on dialysis when used to treat anemia-related symptoms. Documentation of labs, dosage, and clinical justification is required.
Q5105 is billed for ESRD on dialysis in 100-unit increments, while Q5106 is for non-ESRD indications such as chemotherapy-induced anemia, antineoplastic chemotherapy, HIV infection, or hepatitis C treatment, billed in 1,000-unit increments.
EHR and practice management software
Get started for free
*No credit card required
Free
$0/usd
Unlimited clients
Telehealth
1GB of storage
Client portal text
Automated billing and online payments